Evidence-Based Update on Ocular Chemical Injuries

Abstract

Chemical injuries of the eye remain a serious cause of visual disability. The current literature is reviewed, with a focus on recent studies that inform evidence-based treatment decisions. Prevention continues to be a primary goal. In addition to conventional therapy (urgent irrigation, topical corticosteroids and antibiotics, oral vitamin C, possibly doxycycline and topical antioxidants), there is evidence that amniotic membrane, umbilical cord serum, or platelet-rich plasma may improve epithelial healing rates in moderate to severe burns. Reconstruction of the ocular surface continues to evolve; for unilateral disease, simple limbal epithelial transplant (SLET) is gaining momentum. For bilateral total limbal stem cell deficiency, treatment options include allogeneic keratolimbal allograft, ex vivo expansion of cultured epithelial sheets, and keratoprosthesis; each intervention represents a unique balance of risks and benefits. SLET appears to be simple and effective for unilateral limbal stem cell deficiency secondary to chemical injuries. The treatment of bilateral injuries requires additional studies to define the preferred practice patterns, as there is no clear consensus regarding the preferred intervention.